CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.06), versus ($0.06) reported last year. Revenue for the quarter came in at $24 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.